Conversely, pancreatic cancer tissues exhibit a high survivin expression rate of 76.9%, and Bor peptide has been shown to have a promising future in cancer imaging and anti-cancer drugs that target survivin, according to studies [24]. This evidence concerns the gene BIRC5 and familial pancreatic carcinoma.